Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Cytokine|September 1, 2022
Interferon-β promotes the survival and function of induced regulatory T cellsNanako Nishiyama, Chigusa Nakahashi-Oda, Akira ShibuyaImmune Network|January 29, 2010
Regulation of Immune Responses by the Activating and Inhibitory Myeloid-Associate Immunoglobuline-Like Receptors (MAIR) (CD300)Akira Shibuya, Chigusa Nakahashi-Oda, Satoko Tahara-HanaokaJournal of Immunology (Baltimore, Md. : 1950)|April 26, 2015
Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant-Induced Th2 ResponsesHaruka Miki, Chigusa Nakahashi-Oda, Takayuki Sumida, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2019
Cutting Edge: Involvement of the Immunoreceptor CD300c2 on Alveolar Macrophages in Bleomycin-Induced Lung FibrosisYuta Nakazawa, Shigeo Ohtsuka, Chigusa Nakahashi-Oda, et al.International Immunology|November 13, 2016
Immunoreceptor CD300a on mast cells and dendritic cells regulates neutrophil recruitment in a murine model of sepsisKankanam Gamage Sanath Udayanga, Yoshiyuki Nakamura, Chigusa Nakahashi-Oda, et al.Biochemical and Biophysical Research Communications|December 22, 2011
Identification of phosphatidylserine as a ligand for the CD300a immunoreceptorChigusa Nakahashi-Oda, Satoko Tahara-Hanaoka, Shin-ichiro Honda, et al.Elife|November 9, 2021
Tumor-derived extracellular vesicles regulate tumor-infiltrating regulatory T cells via the inhibitory immunoreceptor CD300aYuta Nakazawa, Nanako Nishiyama, Hitoshi Koizumi, et al.International Immunology|September 27, 2018
Identification and isolation of splenic tissue-resident macrophage sub-populations by flow cytometrySatoshi Fujiyama, Chigusa Nakahashi-Oda, Fumie Abe, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|January 13, 2025
A Humanized Monoclonal Antibody Against CD300A Ameliorates Acute Ischemic Stroke in Humanized MiceFumie Abe, Chigusa Nakahashi-Oda, Hanbin Lee, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|October 30, 2023
Development of Monoclonal Antibodies Specific to Either CD300A<sup>R111</sup> or CD300A<sup>Q111</sup> or BothHitoshi Koizumi, Chigusa Nakahashi-Oda, Wenxin Lyu, et al.Pageof 3